Compare NVS & MS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NVS | MS |
|---|---|---|
| Founded | 1895 | 1924 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 292.0B | 342.1B |
| IPO Year | 2001 | 2025 |
| Metric | NVS | MS |
|---|---|---|
| Price | $151.01 | $179.98 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 25 |
| Target Price | $154.65 | ★ $213.27 |
| AVG Volume (30 Days) | 1.5M | ★ 4.4M |
| Earning Date | 10-27-2026 | 10-14-2026 |
| Dividend Yield | 1.97% | ★ 2.50% |
| EPS Growth | N/A | ★ 28.43 |
| EPS | N/A | ★ 6.90 |
| Revenue | N/A | ★ $34,275,000,000.00 |
| Revenue This Year | $1.73 | $16.90 |
| Revenue Next Year | $6.39 | $5.47 |
| P/E Ratio | ★ $23.13 | $26.62 |
| Revenue Growth | N/A | ★ 5.73 |
| 52 Week Low | $121.57 | $152.80 |
| 52 Week High | $170.46 | $232.25 |
| Indicator | NVS | MS |
|---|---|---|
| Relative Strength Index (RSI) | 56.65 | 33.26 |
| Support Level | $149.30 | $177.19 |
| Resistance Level | $155.26 | $192.31 |
| Average True Range (ATR) | 2.26 | 4.60 |
| MACD | 1.29 | 0.30 |
| Stochastic Oscillator | 64.67 | 21.42 |
Novartis develops and manufactures innovative drugs. Key areas of drug development are oncology, immunology, neuroscience, and cardiovascular, renal, and metabolic. It also has an established medicines business, which includes off-patent franchises. The company sells its products globally, with the United States constituting close to one-third of total revenue.
Morgan Stanley is a massive global financial services firm, with offices in 42 countries and more than 82,000 employees as of year-end 2025. The firm cut its teeth in investment banking and institutional trading, where it maintains a strong presence today, but generates the lion share of its income from wealth and asset management franchises, where it boasted $9.3 trillion in client assets at the end of 2025. After reincorporation as a bank holding company in the wake of the global financial crisis, Morgan Stanley also boasts a top 10 banking franchise by deposits, with more than $400 billion in customer deposits, predominately attributable to cash sweeps from its wealth management and brokerage businesses.